Diagnostic value of NSE factor combined with ultrasound hemodynamic indexes in cervical lymph node metastasis of lung cancer

Li,Yansong; Kuang,Yong; Jia,Yanzhen; Bai,Shufang

doi:10.3892/ol.2020.11621

Diagnostic value of NSE factor combined with ultrasound hemodynamic indexes in cervical lymph node metastasis of lung cancer

Authors:
- Yansong Li
- Yong Kuang
- Yanzhen Jia
- Shufang Bai
View Affiliations

Affiliations: Department of Ultrasound, Qingdao Municipal Hospital (Group), Qingdao, Shandong 266011, P.R. China, Department of Physical Diagnostics, Qingdao Ninth People’s Hospital, Qingdao Municipal Hospital (Group), Qingdao, Shandong 266002, P.R. China, Department of Ultrasound, The People's Hospital of Zhangqiu Area, Jinan, Shandong 250200, P.R. China
Published online on: May 14, 2020 https://doi.org/10.3892/ol.2020.11621
Pages: 699-704
Copyright: © Li et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Value of neuron‑specific enolase (NSE) factor combined with ultrasound hemodynamic parameters in the diagnosis of cervical lymph node metastasis of lung cancer was explored. The clinical data of 85 patients with lung cancer, admitted to Qingdao Municipal Hospital (Group) from January 2015 to December 2016, were retrospectively analyzed. According to the results of pathological examination, 47 patients with cervical lymph node metastasis were enrolled in the metastatic group and 38 patients without lymph node metastasis were enrolled in the non‑metastatic group. The expression level of NSE in serum and the hemodynamic indicators of blood flow resistance index (RI) and pulsatility index (PI) were compared between the two groups. ROC curve analysis was used to analyze the diagnostic efficacy of NSE, RI, PI, and their combination in lymph node metastasis of lung cancer. The NSE, RI and PI indexes in the metastatic group were significantly higher than those in the non‑metastatic group (P<0.05). The sensitivity and specificity of NSE in the diagnosis of cervical lymph node metastasis of lung cancer were 73.68 and 72.34%, respectively; the sensitivity and specificity of RI were 78.95 and 80.85%, respectively; the sensitivity and specificity of PI were 81.58 and 68.09%, respectively. Also, the sensitivity and specificity of NSE combined with RI were 89.47 and 61.70%, respectively, and the diagnostic AUC was 0.881. The sensitivity and specificity of NSE combined with PI were 92.11 and 74.47%, respectively, and the diagnostic AUC was 0.905. NSE, RI, and PI have certain diagnostic value for cervical lymph node metastasis of lung cancer, however, the combined diagnosis is more valuable, and can be used as the auxiliary diagnosis of cervical lymph node metastasis of lung cancer.

View Figures

View References

1	Jones JL, Oien KA, Lee JL and Salto-Tellez M: Morphomolecular pathology: Setting the framework for a new generation of pathologists. Br J Cancer. 117:1581–1582. 2017. View Article : Google Scholar : PubMed/NCBI
2	Braunstein S, Wang L, Newhauser W, Tenenholz T, Rong Y, van der Kogel A, Dominello M, Joiner MC and Burmeister J: Three discipline collaborative radiation therapy (3DCRT) special debate: The United States should build additional proton therapy facilities. J Appl Clin Med Phys. 20:7–12. 2019. View Article : Google Scholar : PubMed/NCBI
3	Sun W, Yang X, Liu Y, Yuan Y and Lin D: Primary tumor location is a useful predictor for lymph node metastasis and prognosis in lung adenocarcinoma. Clin Lung Cancer. 18:e49–e55. 2017. View Article : Google Scholar : PubMed/NCBI
4	Li N, Tan F, Li J, Shao K, Zhao J, Mu J, Gao S and He J: Blind spot in lung cancer lymph node metastasis: Cross-lobe peripheral lymph node metastasis in early stage patients. Thorac Cancer. 9:480–485. 2018. View Article : Google Scholar : PubMed/NCBI
5	Korkmaz ET, Koksal D, Aksu F, Dikmen ZG, Icen D, Maden E, Onder S, Akbiyik F and Emri S: Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer. Clin Biochem. 58:15–19. 2018. View Article : Google Scholar : PubMed/NCBI
6	Jiang ZF, Wang M and Xu JL: Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer. Life Sci. 194:1–6. 2018. View Article : Google Scholar : PubMed/NCBI
7	Liu Y, Ren W, Bai Y, Wan L, Sun X, Liu Y, Xiong W, Zhang YY and Zhou L: Oxyresveratrol prevents murine H22 hepatocellular carcinoma growth and lymph node metastasis via inhibiting tumor angiogenesis and lymphangiogenesis. J Nat Med. 72:481–492. 2018. View Article : Google Scholar : PubMed/NCBI
8	Pana ZD, Roilides E, Warris A, Groll AH and Zaoutis T: Epidemiology of invasive fungal disease in children. J Pediatric Infect Dis Soc. 6 (Suppl 1):S3–S11. 2017. View Article : Google Scholar : PubMed/NCBI
9	Pastushenko I, Van den Eynden GG, Vicente-Arregui S, Prieto-Torres L, Alvarez-Alegret R, Querol I, Dirix LY, Carapeto FJ, Vermeulen PB and Van Laere SJ: Increased angiogenesis and lymphangiogenesis in metastatic sentinel lymph nodes is associated with nonsentinel lymph node involvement and distant metastasis in patients with melanoma. Am J Dermatopathol. 38:338–346. 2016. View Article : Google Scholar : PubMed/NCBI
10	Wu X, Takekoshi T, Sullivan A and Hwang ST: Inflammation and tumor microenvironment in lymph node metastasis. Cancers (Basel). 3:927–944. 2011. View Article : Google Scholar : PubMed/NCBI
11	Fitzmaurice C, Dicker D, Pain A, Hamavid H, Moradi-Lakeh M, MacIntyre MF, Allen C, Hansen G, Woodbrook R, Wolfe C, et al Global burden of disease cancer collaboration, : The global burden of cancer 2013. JAMA Oncol. 1:505–527. 2015. View Article : Google Scholar : PubMed/NCBI
12	Vlachogeorgos GS, Manali ED, Blana E, Legaki S, Karagiannidis N, Polychronopoulos VS and Roussos C: Placental isoform glutathione S-transferase and P-glycoprotein expression in advanced nonsmall cell lung cancer: Association with response to treatment and survival. Cancer. 114:519–526. 2008. View Article : Google Scholar : PubMed/NCBI
13	Padera TP, Meijer EF and Munn LL: The lymphatic system in disease processes and cancer progression. Annu Rev Biomed Eng. 18:125–158. 2016. View Article : Google Scholar : PubMed/NCBI
14	Lee DH, Yoon TM, Lee JK and Lim SC: Supraclavicular lymph node excision biopsy in patients with suspected supraclavicular lymph node metastasis of lung cancer: Experience in a Tertiary Hospital. Chonnam Med J. 53:69–72. 2017. View Article : Google Scholar : PubMed/NCBI
15	Pak K, Kim K, Kim MH, Eom JS, Lee MK, Cho JS, Kim YS, Kim BS, Kim SJ and Kim IJ: A decision tree model for predicting mediastinal lymph node metastasis in non-small cell lung cancer with F-18 FDG PET/CT. PLoS One. 13:e01934032018. View Article : Google Scholar : PubMed/NCBI
16	Zhang Q, Wang L, Huang D, Xu M, Weng W, Ni S, Tan C and Sheng W: Pathological risk factors for lymph node metastasis in patients with submucosal invasive colorectal carcinoma. Cancer Manag Res. 11:1107–1114. 2019. View Article : Google Scholar : PubMed/NCBI
17	Chen C, Wang Y, Fu S, Pan X, Yang J and Wang R: The impact on mediastinal recurrence based on the number of harvested mediastinal lymph nodes and assessed N2 Stations in patients with stage I invasive lung adenocarcinoma. J Thorac Dis. 10:6803–6810. 2018. View Article : Google Scholar : PubMed/NCBI
18	Shirasawa M, Fukui T, Kusuhara S, Hiyoshi Y, Ishihara M, Kasajima M, Nakahara Y, Otani S, Igawa S, et al: Prognostic significance of the 8th edition of the TNM classification for patients with extensive disease small cell lung cancer. Cancer Manag Res. 10:6039–6047. 2018. View Article : Google Scholar : PubMed/NCBI
19	Takahashi Y, Suzuki S, Matsutani N and Kawamura M: 18F-fluorodeoxyglucose positron emission tomography/computed tomography in the evaluation of clinically node-negative non-small cell lung cancer. Thorac Cancer. 10:413–420. 2019. View Article : Google Scholar : PubMed/NCBI
20	Hwang HS and Orloff LA: Efficacy of preoperative neck ultrasound in the detection of cervical lymph node metastasis from thyroid cancer. Laryngoscope. 121:487–491. 2011. View Article : Google Scholar : PubMed/NCBI
21	Schneider J, Velcovsky HG, Morr H, Katz N, Neu K and Eigenbrodt E: Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21-1, NSE and SCC in the diagnosis of lung cancer. Anticancer Res. 20:5053–5058. 2000.PubMed/NCBI
22	Shin SH, Kim HS, Jung SH, Xu HD, Jeong YB and Chung YJ: Implication of leucyl-tRNA synthetase 1 (LARS1) over-expression in growth and migration of lung cancer cells detected by siRNA targeted knock-down analysis. Exp Mol Med. 40:229–236. 2008. View Article : Google Scholar : PubMed/NCBI
23	Shao T, Yu L, Li Y and Chen M: Density and SUV ratios from PET/CT in the detection of mediastinal lymph node metastasis in non-small cell lung cancer. Zhongguo Fei Ai Za Zhi. 18:155–160. 2015.(In Chinese). PubMed/NCBI
24	Jiang C, Chen Y, Zhu Y and Xu Y: Systematic review and meta-analysis of the accuracy of 18F-FDG PET/CT for detection of regional lymph node metastasis in esophageal squamous cell carcinoma. J Thorac Dis. 10:6066–6076. 2018. View Article : Google Scholar : PubMed/NCBI
25	Kendirlinan R, Ozkan G, Bayram M, Bakan ND, Tutar M, Gür A and Camsari G: Ultrasound guided fine-needle aspiration biopsy of metastases in nonpalpable supraclavicular lymph nodes in lung cancer patients. Multidiscip Respir Med. 6:220–225. 2011. View Article : Google Scholar : PubMed/NCBI